|
About the Pharmacometric Resources Category
|
|
0
|
1375
|
November 4, 2015
|
|
COVID-19 Resources
|
|
1
|
521
|
April 27, 2020
|
|
COVID-19 Related Clinical Pharmacology or Pharmacometrics Taskforce(s)
|
|
0
|
612
|
March 29, 2020
|
|
DDMoRe Model repository : The challenge is open - who wants to win?
|
|
0
|
1116
|
July 5, 2017
|
|
Model repository challenge: sponsorship open until June 30th
|
|
0
|
974
|
June 19, 2017
|
|
What's Your Emax?
|
|
0
|
1155
|
May 19, 2017
|
|
ISoP Global Survey: "How do you share?"
|
|
8
|
3816
|
October 10, 2016
|
|
ACoP7 Pre-conference Survey: “The Challenging Course of Pediatric Drug Development: What is the Role of Clinical Pharmacology and Pharmacometrics in Bringing New Medicines to this Special Population?”
|
|
8
|
3746
|
April 14, 2016
|
|
Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation (White Paper)
|
|
0
|
1507
|
March 23, 2016
|
|
Digital Curation of Pharmacometric Resources
|
|
0
|
1573
|
February 18, 2016
|
|
Methods and strategies for assessing uncontrolled drug–drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group
|
|
0
|
1507
|
February 14, 2016
|
|
Hosting Pharmacometric Related Applications: The ISOP Shiny Server
|
|
0
|
2077
|
December 29, 2015
|
|
Nmusers listserv
|
|
0
|
2267
|
November 4, 2015
|
|
PAGK (Population Approach Group Korea)
|
|
0
|
1639
|
November 4, 2015
|
|
PAGE (Population Approach Group Europe)
|
|
0
|
1444
|
November 4, 2015
|
|
PKUK (Pharmacokinetics UK)
|
|
0
|
1563
|
November 4, 2015
|
|
PAGANZ (Population Approach Group of Australia and New Zealand)
|
|
0
|
1486
|
November 4, 2015
|
|
Pharmpk (PK/PD Resources)
|
|
0
|
1870
|
November 4, 2015
|
|
ACoP